Clinical Trial Update: Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease

View source ↗

Summary

The document reports the completion of a Bayer-sponsored trial evaluating acarbose as a strategy to prevent postprandial hyperglycemia. The aim is to assess whe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus | Status: COMPLETED